-transparent.png){kind=logo}
Patients with lymphoreticular malignancy were shown by a leucocyte migration inhibition technique to have cellular immunity to Hodgkin's splenic tissue. Migration was significantly inhibited in 31 out of 55 patients with Hodgkin's lymphoma and 19 out of 39 patients with other types of lymphoma. Inhibition was also shown in only three out of 29 patients with other malignancy, one out of 23 normal volunteers, and one out of 25 patients with non-malignant disease. The splenic factor that inhibits leucocyte migration, which has yet to be isolated and identified, may be a helpful diagnostic tool in patients with suspected lymphoma.
Related Publications
B W Hancock, and
L Bruce, and
J Richmond
December 1977,
Journal of the National Cancer Institute,
B W Hancock, and
L Bruce, and
J Richmond
August 1977,
Cancer,
B W Hancock, and
L Bruce, and
J Richmond
April 1975,
Biomedicine / [publiee pour l'A.A.I.C.I.G.],
B W Hancock, and
L Bruce, and
J Richmond
October 1977,
Annals of the rheumatic diseases,
B W Hancock, and
L Bruce, and
J Richmond
March 1976,
British journal of cancer,
B W Hancock, and
L Bruce, and
J Richmond
May 1978,
British journal of cancer,
B W Hancock, and
L Bruce, and
J Richmond
January 1975,
Acta veterinaria Scandinavica,
B W Hancock, and
L Bruce, and
J Richmond
October 1974,
Archives of internal medicine,
B W Hancock, and
L Bruce, and
J Richmond
April 1977,
Cellular immunology,
B W Hancock, and
L Bruce, and
J Richmond
January 1984,
Harefuah,
